↓ Skip to main content

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment

Overview of attention for article published in Blood Cancer Journal, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 1,324)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
51 news outlets
twitter
13 X users
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
63 Mendeley
Title
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment
Published in
Blood Cancer Journal, February 2021
DOI 10.1038/s41408-021-00430-6
Pubmed ID
Authors

Hilma J. van der Horst, A. Vera de Jonge, Ida H. Hiemstra, Anne T. Gelderloos, Daniella R. A. I. Berry, Nathalie J. Hijmering, Hendrik F. van Essen, Daphne de Jong, Martine E. D. Chamuleau, Sonja Zweegman, Esther C. W. Breij, Margaretha G. M. Roemer, Tuna Mutis

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 63 100%

Demographic breakdown

Readers by professional status Count As %
Other 9 14%
Researcher 9 14%
Student > Bachelor 3 5%
Student > Postgraduate 3 5%
Professor 2 3%
Other 6 10%
Unknown 31 49%
Readers by discipline Count As %
Medicine and Dentistry 19 30%
Biochemistry, Genetics and Molecular Biology 5 8%
Immunology and Microbiology 3 5%
Business, Management and Accounting 1 2%
Arts and Humanities 1 2%
Other 2 3%
Unknown 32 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 379. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2024.
All research outputs
#84,823
of 26,014,510 outputs
Outputs from Blood Cancer Journal
#3
of 1,324 outputs
Outputs of similar age
#2,735
of 458,745 outputs
Outputs of similar age from Blood Cancer Journal
#1
of 58 outputs
Altmetric has tracked 26,014,510 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,324 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,745 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.